Cephalexin
Product Images NDC 10544-979

2 FDA label images from Blenheim Phamacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 10544-979). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Phamacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 250mg 30ct (Label Cephalexin Caps 250mg Bpi(10544 979 30) Alkem(67877 220 05) Rev1)

Label 250mg 30ct (Label Cephalexin Caps 250mg Bpi(10544 979 30) Alkem(67877 220 05) Rev1)
Label for Cephalexin Capsules, USP 250mg by Blenheim Pharmacal, Inc., containing 30 capsules. The label includes storage instructions to keep at 20°-25°C and in a light-resistant container, with warnings to keep out of reach of children. It displays the NDC 10544-979-30 and the manufacturer lot number and expiration date fields.*
FDA Label Image

Cephalexin Structure (Str 1)

Cephalexin Structure (Str 1)
Chemical structure of Cephalexin monohydrate, showing its molecular framework including a beta-lactam ring and side groups characteristic of this antibiotic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.